All Stories

  1. Reducing re-hospitalization in schizophrenia: real-world comparison of first- vs. second-generation long-acting injectable antipsychotics
  2. Glutamatergic Modulators in Schizophrenia: Are We Ready to Move Beyond the Narrow Focus on Dopamine? A Potential Paradigm Shift in Psychopharmacology
  3. Apathy phenotypes in depression and dementia: A latent profile analysis
  4. Estimating the Minimal Detectable Change (MDC) of the Disability of the Arm, Shoulder and Hand (DASH) scale in idiopathic frozen shoulder
  5. Psychiatrists’ role in disaster situations: A narrative review of empirical evidence
  6. Sleep Quality Profiles in Youth with Eating Disorders: A Latent Profile Analysis
  7. Updating clozapine prescribing guidelines in Italy: a step forward modernity
  8. Disentangling food addiction–related symptom profiles in anorexia nervosa: a latent class analysis and clinical implications
  9. The Key to Clozapine Mystery May Lie in its Shape
  10. Shared decision making in eating disorders: the patient and clinician perspectives
  11. Depression and apathy: examining an overlooked dimension
  12. Metabolomics biomarkers for precision psychiatry
  13. Impact of treatment with long‑acting injectable antipsychotics on hospitalization and relapse rates in schizophrenia spectrum disorders: a 3‑year follow-up mirror‑image study
  14. Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel
  15. Exploring the effects of pharmacological treatments on suicidality in children and adolescents: a structured review of the literature and narrative synthesis
  16. Early career psychiatrists’ ability to evaluate and manage negative symptoms of schizophrenia – results from a European survey
  17. Body Image: A Bridge Between Depression and Quality of Life in Women With Cancer
  18. Editorial: Community series in mental-health-related stigma and discrimination: prevention, role, and management strategies, volume III
  19. Beyond diagnosis: Examining body dissatisfaction across obesity and eating disorders
  20. Early Maladaptive Schemas as Core Therapeutic Targets in Eating Disorders and Obesity: A Schema Therapy–Informed Network Analysis
  21. Understanding food addiction in obesity: a genetic perspective
  22. The place of risperidone in situ microparticles (ISM®) among long-acting injectable antipsychotics in schizophrenia treatment
  23. Editorial: Standardizing cognitive endophenotype profiling in bipolar disorder and schizophrenia
  24. Editorial: Safety and side effects of psychotropic medications, volume III
  25. Early Maladaptive Schemas Mediate the Relationship Between Childhood Trauma and Interpersonal Problems in Eating Disorders
  26. Somatization Across Cultures
  27. The Greater the Number of Altered Eating Behaviors in Obesity, the More Severe the Psychopathology
  28. The Association Between Antipsychotics and Bone Fragility: An Updated Comprehensive Review
  29. Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders
  30. Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salience
  31. Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia
  32. Applying a clinical staging model in patients affected by schizophrenia spectrum disorder
  33. Metacognition as a transdiagnostic factor across eating disorders: a latent profile analysis study
  34. The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment
  35. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic, volume VIII
  36. Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
  37. Editorial: The experiences of mental health professionals in psychiatric settings
  38. Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
  39. Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial
  40. Editorial: Community series in mental-health-related stigma and discrimination: prevention, role, and management strategies, volume II
  41. Obsessive–Compulsive Disorder as an Epiphenomenon of Comorbid Bipolar Disorder? An Updated Systematic Review
  42. The role of arts in moderating mental health-related stigma: views of early career psychiatrists and trainees from different parts of the world
  43. Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity
  44. Stigma toward substance use disorders: a multinational perspective and call for action
  45. Using latent class analysis to identify different clinical profiles according to food addiction symptoms in obesity with and without binge eating disorder
  46. Variations in obsessive compulsive disorder symptomatology across cultural dimensions
  47. The Impact of Job on Mental Health
  48. Early career psychiatrists’ perceptions of and training experience in electroconvulsive therapy: A cross-sectional survey across Europe
  49. Impact of stigma on the placement of mental health facilities: insights from early career psychiatrists worldwide
  50. Parity of esteem: A global COVID-19 vaccination approach for people with mental illnesses, based on facts from 34 countries; recommendations and solutions
  51. Editorial: Safety and side effects of psychotropic medications, volume II
  52. Mental illness stigma among perinatal women in low- and middle-income countries: early career psychiatrists' perspective
  53. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
  54. Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel
  55. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
  56. The relationship of food addiction with binge eating disorder and obesity: A network analysis study
  57. Head Regional Differences in Thermal Comfort: Evaluating a Novel Surgical Helmet Cooling Method with Phase Change Material
  58. Reactive hypoglycemia in binge eating disorder, food addiction, and the comorbid phenotype: unravelling the metabolic drive to disordered eating behaviours
  59. An update from the WPA Working Group on Digitalization in Mental Health and Care
  60. Pain experience in eating disorders: The mediating role of depression, alexithymia and interoceptive awareness
  61. Cognitive biases are associated with aberrant salience experience in schizophrenia spectrum disorders
  62. Defining the minimum clinically important difference (MCID) in the hospital anxiety and depression scale (HADS) in patients undergoing total hip and knee arthroplasty
  63. Collaborative research on mental health in the post-COVID-19 era: an early career psychiatrists' perspective
  64. Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report
  65. Sleep Disturbances in Panic Disorder with Comorbid Complex PTSD: A Possible Relationship and Different Psychopathology?
  66. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic, volume VII
  67. Testing psychometric properties of Shared Decision Making Questionnaire – Physician Version (SDM-Q-Doc) in an Italian real-world psychiatric clinical sample
  68. Systemic Racism, Ethnic Discrimination, and Children’s Mental Health: Fostering Global Conversations
  69. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic, volume VI
  70. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic: volume V
  71. Editorial: Mental health and internalized stigma in people with severe mental illness
  72. Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database
  73. Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study
  74. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic - Volume IV
  75. Sleep Disturbances in Generalized Anxiety Disorder: The Role of Calcium Homeostasis Imbalance
  76. Postoperative psychological factors and quality of life but not shoulder brace adherence affect clinical outcomes after arthroscopic rotator cuff repair
  77. The mediation role of impulsivity between childhood trauma and dissociative symptomatology in bipolar disorder
  78. Editorial: Safety and side effects of psychotropic medications
  79. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic - Volume III
  80. Mental health-related stigma in movies: A call for action to the cinema industry
  81. Editorial: Mental-health-related stigma and discrimination: Prevention, role, and management strategies
  82. Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
  83. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic—Volume II
  84. Editorial: Mental illness, culture, and society: Dealing with the COVID-19 pandemic
  85. The use of antidepressants is linked to bone loss: A systematic review and metanalysis
  86. The Mediation Effect of Peripheral Biomarkers of Calcium Metabolism and Chronotypes in Bipolar Disorder Psychopathology
  87. Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review
  88. Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool
  89. Is everyone invited to the discussion table? A Bibliometric Analysis COVID-19 Related Mental Health Literature
  90. Internalized-stigma and dissociative experiences in bipolar disorder
  91. Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders
  92. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases
  93. 10th EPA Summer School on Research 2021: sharing experience of the first online edition
  94. THE RISING SCOURGE OF MENTAL ILLNESS AND INFODEMIC: AN OUTCOME OF SOCIAL MEDIA AND COVID-19
  95. EFFECTS OF THE GLOBAL ECOLOGICAL CRISIS ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS: AN INTERNATIONAL PERSPECTIVE
  96. The grief experience during the COVID-19 pandemic across different cultures
  97. Two Cases of Olfactory Reference Syndrome Treated with Risperidone
  98. Associations of lockdown stringency and duration with Google searches for mental health terms during the COVID-19 pandemic: A nine-country study
  99. Depression and anxiety among Pakistani healthcare workers amid COVID-19 pandemic: A qualitative study
  100. Nicotine replacement gums dependence: A case report of a new potential addiction
  101. Palatal myoclonus with tinnitus treated as a psychogenic disorder for 35-years
  102. Primary Obsessive Slowness: A Complex Presentation and Treatment Difficulties
  103. Validation of the Italian version of the Davos Assessment of Cognitive Biases Scale (DACOBS) in a sample of schizophrenia spectrum disorder patients and healthy controls
  104. Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
  105. Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome
  106. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
  107. Support the frontliners – good initiatives during the COVID-19 pandemic for healthcare workers across the world: is this what we really need?
  108. Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond
  109. Development, validation and clinical use of the Eating Behaviors Assessment for Obesity (EBA-O)
  110. Nutrition and Depression
  111. The Mental Health of Caregivers and Their Patients With Dementia During the COVID-19 Pandemic: A Systematic Review
  112. Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
  113. How to overcome barriers to publication in low‐ and middle‐income countries: Recommendations from early career psychiatrists and researchers from around the world
  114. How is the COVID-19 pandemic affecting women's menstrual cycles and quality of life? A view from South Asia
  115. Awareness of illness moderates self-assessment of psychotic symptoms
  116. Prevalence of impaired kidney function in patients with long‐term lithium‐treatment: a systematic review and meta‐analysis
  117. Dissociative Symptoms in Bipolar Disorder: Impact on Clinical Course and Treatment Response
  118. Olanzapine-Related Somnambulism
  119. La représentation des femmes dans les comités éditoriaux des revues de psychiatrie : multiples défis et obstacles
  120. Fear During COVID-19 pandemic: Fear of COVID-19 Scale Measurement Properties
  121. Mental status via telepsychiatry: The potential pitfalls
  122. Suicidal behavior sociocultural factors in developing countries during COVID-19
  123. Role of Social Media in Psychiatry During Pandemic
  124. A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome
  125. Impact of videoconferencing applications on mental health
  126. Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis
  127. Executive functions and depressive symptoms interplay in binge eating disorder: A structural equation model analysis
  128. Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
  129. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
  130. Suicide is multifactorial: There should be a difference between a news report and a scientific report of suicide
  131. Coronavirus outbreak from early career psychiatrists' viewpoint: What we have learned so far
  132. Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review
  133. Challenges and Opportunities of Psychiatric Training During COVID-19: Early Career Psychiatrists’ Perspective Across the World
  134. Dissociative Symptoms and Psychotic Features in Bipolar Disorder: Impact on Clinical Course and Treatment Response
  135. Current and emerging long-acting antipsychotics for the treatment of schizophrenia
  136. Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
  137. Internet and Pornography Use During the COVID-19 Pandemic: Presumed Impact and What Can Be Done
  138. COVID-19 & psychiatric care: Need of a plan to prevent follow-up discontinuation
  139. Antisocial Personality Disorder in Bipolar Disorder: A Systematic Review
  140. Clinical Impact of Psychopathy on Bipolar Disorder
  141. Telepsychiatry in Low- and Middle-Income Countries During COVID-19
  142. Matrix Metalloproteinase 9 Blood Alterations in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis
  143. Current state of cannabis use, policies, and research across sixteen countries: Cross-Country Comparisons and International perspectives
  144. 24-hour mobile phone helpline service for women discharged from mother-baby psychiatry unit (MBU): Is it possible?
  145. IMPACT OF BIPOLAR DISORDER AND OBSESSIVE-COMPULSIVE DISORDER COMORBIDITY ON NEUROCOGNITIVE PROFILE: A MINI-REVIEW
  146. It’s COVID o’clock—time to publish or perish
  147. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms
  148. Postoperative heroin-withdrawal delirium treated with clonazepam after urgent cardiac surgery: a case report
  149. Effect of COVID-19 on Mental Health Rehabilitation Centers
  150. Infectious disease outbreak related stigma and discrimination during the COVID-19 pandemic: Drivers, facilitators, manifestations, and outcomes across the world
  151. Management of psychiatric conditions and delirium during the COVID-19 pandemic across continents: The lessons thus far
  152. Pathways to orthorexia nervosa: a case series discussion
  153. The urge to implement and expand telepsychiatry during the COVID-19 crisis: Early career psychiatrists’ perspective
  154. Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review
  155. Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review
  156. La urgencia de implementar y ampliar la telepsiquiatría durante la crisis de COVID-19: perspectiva de los psiquiatras que inician su carrera
  157. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder
  158. Second-generation long-acting injections anti-psychotics improve executive functions in patients with schizophrenia: a 12-month real-world study
  159. Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms
  160. ‘Impaired Autonomy and Performance’ predicts binge eating disorder among obese patients
  161. Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review
  162. Weight and age do not account for a worse executive functioning among BED-obese patients
  163. Effectiveness of integrated psychological therapy on clinical, neuropsychological, emotional and functional outcome in schizophrenia: a RCT study
  164. Bipolar disorder and obsessive compulsive disorder: The comorbidity does not further impair the neurocognitive profile